Clear lens extraction to correct hyperopia

J Cataract Refract Surg. 1997 Sep;23(7):1051-6. doi: 10.1016/s0886-3350(97)80079-x.

Abstract

Purpose: To evaluate the effectiveness and safety of clear lens extraction with intraocular lens (IOL) implantation to correct hyperopia and to determine the most accurate and predictable method of IOL power selection.

Setting: The Eye Institute of Utah, Salt Lake City, Utah, USA.

Methods: The outcome of 20 phacoemulsification and IOL implantation procedures was assessed at a mean follow-up of 23.2 months (range 3 to 60 months). Intraocular lens power and predicted refraction were retrospectively evaluated in each eye with the SRK II and Holladay formulas with different attempted refractions based on the stabilized postoperative refraction.

Results: Uncorrected visual acuity (UCVA) improved from 20/200 preoperatively to 20/30 postoperatively. At the final examination, 89% of eyes achieved 20/40 or better UCVA. All eyes had 20/25 or better best corrected visual acuity (BCVA). No eye lost two or more Snellen lines of BCVA. There were no surgical or postoperative complications. The Holladay formula was more accurate than the SRK II formula. With the Holladay formula aiming for -1.00 diopter (D), the predicted mean postoperative spherical equivalent would be -0.21 D +/- 0.89 (SD); with the SRK II aiming for -1.50 D, it would be +0.43 +/- 1.10 D. The Holladay formula reduced the chance of postoperative residual hyperopia.

Conclusion: Clear lens extraction with IOL implantation was an effective, safe procedure for the correction of hyperopia. However, this method was less accurate and less predictable for hyperopia below +3.00 D. With the Holladay formula aiming for -1.00 D, good visual and refractive results can be expected. Further study with a larger sample of patients and longer follow-up is needed to assess long-term safety and effectiveness.

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperopia / surgery*
  • Lens Implantation, Intraocular
  • Lens, Crystalline / surgery*
  • Male
  • Middle Aged
  • Phacoemulsification
  • Safety
  • Treatment Outcome
  • Visual Acuity